Risks of Low HDLs: What If LDLs Are Also Low?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Clinician and lipid researcher Dr. Philip Barter of the Heart Research Institute in Sydney, Australia, shares with us his research about the risk of low HDL, even in the face of very low LDL levels.
Overview
Clinician and lipid researcher Dr. Philip Barter of the Heart Research Institute in Sydney, Australia, shares with us his research about the risk of low HDL, even in the face of very low LDL levels.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Level Up Your Skills: Tailoring Management of HF
Personalizing Care Within the RCC Treatment Paradigm
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?